Canada Life’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Canada Life’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,140	Closed	-$207K	–	2724
2015 Q1	$207K	Buy	2,140 +140	+7%	+$14.8K	﹤0.01%	1333
2014 Q4	$185K	Hold	2,000	–	–	﹤0.01%	1347
2014 Q3	$138K	Hold	2,000	–	–	﹤0.01%	1446
2014 Q2	$209K	Hold	2,000	–	–	﹤0.01%	1115
2014 Q1	$165K	Hold	2,000	–	–	﹤0.01%	1199
2013 Q4	$130K	Buy	+2,000	New	+$119K	﹤0.01%	1285

Canada Life's GEVA Position: Q2 2015 in Review

Canada Life sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 2,140 shares — an estimated $207K sold.

Canada Life first reported a position in GEVA in Q4 2013 and held it in 6 quarters. The position peaked at $209K in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Canada Life reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Canada Life sold 2,140 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $207K.
Canada Life first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2013 and held it in 6 quarters.
Canada Life's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $209K in Q2 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Canada Life's 13F filing for Q2 2015, filed 11 Aug 2015.